Peliosis hepatis: Difference between revisions

Jump to navigation Jump to search
 
(15 intermediate revisions by 8 users not shown)
Line 1: Line 1:
{{Infobox_Disease
__NOTOC__
| Name          = {{PAGENAME}}
{{Peliosis hepatis}}
| Image          =
{{CMG}}; {{AE}} {{FH}}[[Adenike Eketunde]]
| Caption        =
| DiseasesDB    =
| ICD10          = {{ICD10|K|76|4|k|70}}
| ICD9          =
| ICDO          =
| OMIM          =
| MedlinePlus    =
| eMedicineSubj  =
| eMedicineTopic =
| MeshID        = D010382
}}
{{Search infobox}}


{{CMG}}
==[[Peliosis hepatis overview|Overview]]==


==[[Peliosis hepatis historical perspective|Historical Perspective]]==


==[[Peliosis hepatis classification|Classification]]==


==Overview==
==[[Peliosis hepatis pathophysiology|Pathophysiology]]==
'''Peliosis Hepatis''' is an uncommon [[Blood vessel|vascular]] condition characterised by randomly distributed multiple blood-filled cavities throughout [[liver]]. Size of the cavities usually ranges between a few millimetres to 3 cm in diameter<ref name="marvin">{{cite book | last = Sleisenger | first = Marvin | title = Sleisenger and Fordtran's Gastrointestinal and Liver Disease | publisher = W.B. Saunders Company | location = Philadelphia | year = 2006 |isbn = 1416002456 }} Chapter 80  </ref>. In the past it was a mere [[histological]] curiosity  occasionally found at [[autopsies]] but has been increasingly recognised with wide ranging conditions from [[AIDS]] to the use of [[anabolic steroid]]s. It also occasionally affects [[spleen]], [[lymph nodes]], [[lungs]], [[kidneys]], [[adrenal glands]], [[bone marrow]] and other parts of [[gastrointestinal tract]].<ref>{{cite journal |author=Ichijima K, Kobashi Y, Yamabe H, Fujii Y, Inoue Y |title=Peliosis hepatis. An unusual case involving multiple organs |journal=Acta Pathol. Jpn. |volume=30 |issue=1 |pages=109-20 |year=1980 |pmid=7361545}}</ref>. 


Peliosis hepatis is often erroneously written "peliosis hepati''ti''s", despite its not being one of the [[hepatitis|hepatitides]].  The correct term arises from the Greek ''pelios'', i.e. discoloured by extravasated blood, livid<ref>{{cite web |url=http://www.perseus.tufts.edu/cgi-bin/ptext?doc=Perseus%3Atext%3A1999.04.0057%3Aentry%3D%2380479 |title=Henry George Liddell, Robert Scott, A Greek-English Lexicon |accessdate=2007-06-11 |format= |work=}}</ref>, and the Latinized Genitive case (hepatis<ref>{{cite web |url=http://www.perseus.tufts.edu/cgi-bin/ptext?doc=Perseus%3Atext%3A1999.04.0059%3Aentry%3D%2320439 |title=Charlton T. Lewis, Charles Short, A Latin Dictionary |accessdate=2007-07-02 |format= |work=}}</ref>) of the Greek ''hepar'', liver<ref>{{cite web |url=http://www.perseus.tufts.edu/cgi-bin/ptext?doc=Perseus%3Atext%3A1999.04.0057%3Aentry%3D%2347443 |title=Henry George Liddell, Robert Scott, A Greek-English Lexicon |accessdate=2007-07-02 |format= |work=}}</ref>.
==[[Peliosis hepatis causes|Causes]]==


== Pathophysiology ==
==[[Peliosis hepatis differential diagnosis|Differentiating Peliosis hepatis from Other Diseases]]==
The [[pathogenesis]] of peliosis hepatis is unknown. There are several [[Hypothesis|hypotheses]], such as, it arise from [[sinusoidal]] epithelial damage<ref>{{cite journal |author=Gushiken FC |title=Peliosis hepatis after treatment with 2-chloro-3'-deoxyadenosine |journal=South. Med. J. |volume=93 |issue=6 |pages=625-6 |year=2000 |pmid=10881786}}</ref>, increased sinusoidal pressure due to obstruction in blood outflow from the liver, or hepatocellular [[necrosis]]<ref name="marvin"/>.


Two [[morphology (biology)|morphologic]] patterns of hepatic peliosis were described by Yanoff and Rawson <ref>{{cite journal |author=YANOFF M, RAWSON AJ |title=PELIOSIS HEPATIS. AN ANATOMIC STUDY WITH DEMONSTRATION OF TWO VARIETIES |journal=Archives of pathology |volume=77 |issue= |pages=159-65 |year=1964 |pmid=14088761}}</ref>. In the '''phlebectatic''' type, the blood-filled spaces are lined with [[endothelium]] and are associated with [[aneurysm|aneurism]]al dilatation of the central vein; in the '''parenchymal''' type, the spaces have no endothelial lining and they usually are associated with [[haemorrhagic]] [[parenchyma]]l [[necrosis]]. Some considers both pattern to be one process, initiated by focal [[necrosis]] of liver parenchyma observed in parenchymal type progressing into formation of [[fibrous]] wall and endothelial lining around [[haemorrhage]] of phebectatic type. [[Fibrosis]], [[cirrhosis]], regenerative nodules, and [[tumor|tumours]] may also be seen.
==[[Peliosis hepatis epidemiology and demographics|Epidemiology and Demographics]]==


===Causes===
==[[Peliosis hepatis risk factors|Risk Factors]]==  


===Drug Causes===
==[[Peliosis hepatis screening|Screening]]==  


* [[Oxandrolone]]
==[[Peliosis hepatis natural history, complications and prognosis|Natural History, Complications, and Prognosis]]==
* [[Nandrolone]]
* [[oxymetholone]]


== Disease associations ==
==Diagnosis==
*'''Infections:''' [[HIV]], Bacillary peliosis (caused by genus  ''[[Bartonella]]'', bacteria responsible for [[cat-scratch disease]] which are identified histologically adjacent to the peliotic lesions<ref>{{cite journal |author=Koehler JE, Sanchez MA, Garrido CS, Whitfeld MJ, Chen FM, Berger TG, Rodriguez-Barradas MC, LeBoit PE, Tappero JW |title=Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis |journal=N. Engl. J. Med. |volume=337 |issue=26 |pages=1876-83 |year=1997 |pmid=9407154}}</ref>), ''[[Staphylococcus aureus]]''<ref>{{cite journal |author=Perkocha LA, Geaghan SM, Yen TS, Nishimura SL, Chan SP, Garcia-Kennedy R, Honda G, Stoloff AC, Klein HZ, Goldman RL |title=Clinical and pathological features of bacillary peliosis hepatis in association with human immunodeficiency virus infection |journal=N. Engl. J. Med. |volume=323 |issue=23 |pages=1581-6 |year=1990 |pmid=2233946}}</ref>
[[Peliosis hepatis history and symptoms|History and Symptoms]] | [[Peliosis hepatis physical examination|Physical Examination]] | [[Peliosis hepatis laboratory findings|Laboratory Findings]] | [[Peliosis hepatis electrocardiogram|Electrocardiogram]] | [[Peliosis hepatis chest x ray|Chest X Ray]] | [[Peliosis hepatis CT|CT]] | [[Peliosis hepatis MRI|MRI]] | [[Peliosis hepatis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Peliosis hepatis other imaging findings|Other Imaging Findings]] | [[Peliosis hepatis other diagnostic studies|Other Diagnostic Studies]]
*'''Chronic conditions:'''  End stage [[renal failure]], [[Kwashiorkor]], [[tuberculosis]] and other chronic infections.
*'''Malignancy:''' [[Monoclonal gammopathy|Monoclonal gammopathies]] ([[multiple myeloma]] and [[Waldenstrom macroglobulinemia]]), [[Hodgkin's disease]], [[malignant histiocytosis]], [[seminoma]], [[hepatocellular adenoma]] and [[Hepatocellular carcinoma|hepatocarcinoma]],<ref>{{cite journal |author=Haboubi NY, Ali HH, Whitwell HL, Ackrill P |title=Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations |journal=Am. J. Gastroenterol. |volume=83 |issue=3 |pages=256-61 |year=1988 |pmid=3278593}}</ref>
* '''Renal transplants:'''  It can be found in up to 20% patients, can be related to azathioprine or cyclosporine use and may be associated with increased risk of [[transplant rejection]]<ref>{{cite journal |author=Izumi S, Nishiuchi M, Kameda Y, Nagano S, Fukunishi T, Kohro T, Shinji Y |title=Laparoscopic study of peliosis hepatis and nodular transformation of the liver before and after renal transplantation: natural history and aetiology in follow-up cases |journal=J. Hepatol. |volume=20 |issue=1 |pages=129-37 |year=1994 |pmid=8201214}}</ref><ref>{{cite journal |author=Cavalcanti R, Pol S, Carnot F, Campos H, Degott C, Driss F, Legendre C, Kreis H |title=Impact and evolution of peliosis hepatis in renal transplant recipients |journal=Transplantation |volume=58 |issue=3 |pages=315-6 |year=1994 |pmid=8053054}}</ref>.
*'''Drugs and toxins:''' [[Corticosteroids]], [[androgens]], [[methyltestosterone]], [[azathioprine]], [[tamoxifen]]<ref>{{cite book | last = Goldman | first = Lee | title = Cecil Textbook of Medicine -- 2-Volume Set, Text with Continually Updated Online Reference | publisher = W.B. Saunders Company | location = Philadelphia | year = 2003 | isbn = 0721645631 }}</ref>


== Clinical features ==
==Treatment==
The condition is typically asymptomatic and is discovered following evaluation of abnormal [[liver function test]]. However, when severe it can manifest as [[jaundice]], [[hepatomegaly]], [[liver failure]] and [[Hemoperitoneum|haemoperitoneum]].
[[Peliosis hepatis medical therapy|Medical Therapy]] | [[Peliosis hepatis surgery|Surgery]] | [[Peliosis hepatis primary prevention|Primary Prevention]] | [[Peliosis hepatis secondary prevention|Secondary Prevention]] | [[Peliosis hepatis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Peliosis hepatis future or investigational therapies|Future or Investigational Therapies]]


== Treatment ==
==Case Studies==
Usually directed towards management of underlying cause. Withdrawal of azathioprine leads to remission in [[Kidney transplantation|renal transplant]], bacillary peliosis responds to antibiotics. In rare circumstances partial resection of liver or [[Liver transplantation|transplant]] may be required.
[[Peliosis hepatis case study one|Case #1]]


== Other cystic conditions of liver ==
*[[Polycystic Liver Disease]]
*Solitary congenital cysts
*[[Congenital hepatic fibrosis]]
*[[Hydatid cyst]]
*Von Meyenburg complexes
*[[Caroli disease]] (type V choledochal cyst)
*Type IV [[choledochal cysts]]
== References ==
{{Reflist|2}}
{{Gastroenterology }}
{{Cystic diseases}}
[[de:Peliosis hepatis]]
[[Category:Gastroenterology]]
[[Category:Pathology]]
[[Category:Needs patient information]]
[[Category:Mature chapter]]
[[Category:Hepatology]]
[[Category:Hepatology]]


{{WikiDoc Help Menu}}
{{WH}}
{{WikiDoc Sources}}
{{WS}}

Latest revision as of 14:41, 5 January 2021

Peliosis hepatis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Peliosis hepatis from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Peliosis hepatis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Peliosis hepatis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Peliosis hepatis

CDC on Peliosis hepatis

Peliosis hepatis in the news

Blogs on Peliosis hepatis

Directions to Hospitals Treating Peliosis hepatis

Risk calculators and risk factors for Peliosis hepatis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farwa Haideri [2]Adenike Eketunde

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Peliosis hepatis from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:WH Template:WS